Characteristic analysis of clinical coronary heart disease and coronary artery disease concerning young and middle-aged male patients

Table 1 Analysis of the basic clinical data in between-group patients, mean ± SD or n (%)

Factor	Young group, n = 55	Middle-aged group, n = 55	t/X2	P value
Age	36.12 ± 4.25	71.36 ± 5.43	37.9012	0.0000
Diabetes	8 (14.54)	35 (63.63)	27.8341	0.0000
Hypertension	9 (16.36)	39 (70.90)	33.2661	0.0000
Smoking history	20 (36.36)	31 (56.36)	4.4234	0.0354
BMI in kg/m2	27.35 ± 3.33	25.08 ± 2.19	4.2238	0.0001
Family history of CHD	4 (7.27)	12 (21.81)	4.6809	0.0305
Hyperuricemia	3 (5.45)	23 (4.18)	20.1465	0.0000
Dyslipidemia	20 (36.36)	22 (40.00)	0.1541	0.6946
Myocardial infarction	17 (30.90)	30 (54.54)	6.2783	0.0122
Drinking history	19 (34.54)	7 (12.72)	7.2527	0.0070
Stroke history	2 (3.63)	6 (10.90)	2.1569	0.1419

CHD: Coronary heart disease; BMI: Body mass index.

Table 2 Analysis of coronary artery lesion characteristics in between-group patients, n (%)

Group	Gensini score > 50	Collateral circulation	MVD	DVD	SVD	Right coronary artery	Left main coronary artery
Young, n = 55	10 (18.18)	11 (20.00)	6 (10.90)	8 (14.54)	17 (30.90)	10 (18.18)	2 (3.63)
Middle-aged, n = 55	24 (43.63)	23 (41.81)	19 (34.54)	17 (30.90)	7 (12.72)	22 (40.00)	8 (14.54)
X2	8.3437	6.1300	8.7482	4.1929	5.3295	6.3462	3.9600
P value	0.0038	0.0132	0.0030	0.0405	0.0209	0.0117	0.0465

MVD: Multivessel disease; DVD: Double vessel disease; SVD: Single vessel disease.

Table 3 Factor analysis of blood lipid related index in between-group patients (mean ± SD)

Group	Serum uric acid, μmol/L	Fibrinogen, g/L	HDL-C, mmol/L	LDL-C, mmol/L	Triacylglycerol, mmol/L	Total cholesterol, mmol/L
Young, n = 55	285 ± 17	3.22 ± 0.95	1.12 ± 0.36	2.81 ± 0.46	2.13 ± 0.66	4.60 ± 0.57
Middle-aged, n = 55	386 ± 19	2.75 ± 0.71	1.02 ± 0.35	2.41 ± 0.23	1.97 ± 0.53	4.13 ± 0.41
X2	29.3796	2.9389	1.4770	5.7680	1.4018	4.9642
P value	0.0000	0.0040	0.1426	0.0000	0.1638	0.0000

HDL-C: High-density lipoprotein cholesterol; LDL-C: Low-density lipoprotein cholesterol.